CSL Seeks to Solidfy its Position by Acquiring Talecris
By Taskin Ahmed
Pharma Deals Review: Vol 2008 Issue 99 (Table of Contents)
Published: 12 Aug-2008
DOI: 10.3833/pdr.v2008.i99.147 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
CSL has agreed to buy Talecris Biotherapeutics for US$3...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018